AASLD


Also found in: Acronyms.

AASLD

American Association for the Study of Liver Diseases.
Mentioned in ?
References in periodicals archive ?
The WHO, AASLD, APASL, and EASL guidelines recommend the monitoring of HBeAg status, HBV DNA level, and ALT level for detection of HBV infection phase.
Patients with NAFLD cirrhosis should be screened and managed for gastroesophageal varices according to AASLD practice guidelines [56]: (1) Patients with compensated cirrhosis (CC) without varices on screening endoscopy should have endoscopy repeated every 2 years; patients with CC with small varices on screening endoscopy should have endoscopy repeated every year; patients with CC without varices or with small varices who develop decompensation should have a repeat endoscopy when this occurs.
HCC diagnosis was determined by tissue biopsy or typical imaging findings according to AASLD guidelines [22].
In 66th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD).
HCC treatment was based on the guidelines of the American Association for the Study of Liver Diseases (AASLD) for the clinical treatment of HCC.
The American Association for the Study of Liver Diseases (AASLD) (Terrault et al., 2016) published several recommendations for treatment and monitoring of CHB based on the phase of disease.
The study presented at The Liver Meeting held by the American Association for the Study of Liver Diseases (AASLD).
NORDIC BUSINESS REPORT-October 2, 2017-Wilson Therapeutics reports promising preliminary long-term data from WTX101 Phase 2 extension study to be presented at AASLD Annual Meeting
* 2 Asociaciones Cientificas Internacionales a las que pertenece: Colegio Americano de Gastroenterologia (ACG) y Asociacion Americana para el Estudio de las Enfermedades Hepaticas (AASLD).
(4.) American Association for the Study of Liver Diseases (AASLD);Infectious Disease Society of America (IDSA).
However, clinical guidelines from the American Association for the Study of Liver Diseases (4) (AASLD) recommend testing for Q80K in genotype 1a prior to using simeprevir in interferon-containing regimens, and more recently in cirrhotic patients that are going to start sofosbuvir (SOF) and simeprevir (SIM).
The American Association for the Study of Liver Diseases (AASLD) defines acute fulminant liver failure as an acute deterioration of function resulting in altered mentation and coagulopathy without any known preexisting disease [1].